In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse
- Authors:
- Weiguo Hong
- Yan Hu
- Zhenping Fan
- Rong Gao
- Ruichuang Yang
- Jingfeng Bi
- Jun Hou
-
Affiliations: Clinical Research and Management Center, Fifth Medical Center, Chinese PLA General Hospital, Beijing 100039, P.R. China, Liver Disease Center for Cadre Medical Care, Fifth Medical Center, Chinese PLA General Hospital, Beijing 100039, P.R. China - Published online on: December 2, 2019 https://doi.org/10.3892/ol.2019.11171
- Pages: 952-964
-
Copyright: © Hong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jung KH, Zhang J, Zhou C, Shen H, Gagea M, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK and Beretta L: Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. Hepatology. 63:864–879. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Llovet JM, Fuster J and Bruix J; Barcelona-Clínic Liver Cancer Group, : The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 10:S115–S120. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Welker MW, Bechstein WO, Zeuzem S and Trojan J: Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge. Transpl Int. 26:109–118. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Darnell JE Jr: Transcription factors as targets for cancer therapy. Nat Rev Cancer. 2:740–749. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Malz M, Pinna F, Schirmacher P and Breuhahn K: Transcriptional regulators in hepatocarcinogenesis-key integrators of malignant transformation. J Hepatol. 57:186–195. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huh HD, Kim DH, Jeong HS and Park HW: Regulation of TEAD transcription factors in cancer biology. Cells. 8:6002019. View Article : Google Scholar | |
|
Luo D, Wang Z and Wu J, Jiang C and Wu J: The role of hypoxia inducible factor-1 in hepatocellular carcinoma. Biomed Res Int. 2014:4092722014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin D and Wu J: Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target. World J Gastroenterol. 21:12171–12178. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Méndez-Blanco C, Fondevila F, García-Palomo A, González-Gallego J and Mauriz JL: Sorafenib resistance in hepatocarcinoma: Role of hypoxia-inducible factors. Exp Mol Med. 50:1342018. View Article : Google Scholar : PubMed/NCBI | |
|
De Matteis S, Scarpi E, Granato AM, Vespasiani-Gentilucci U, La Barba G, Foschi FG, Bandini E, Ghetti M, Marisi G, Cravero P, et al: Role of SIRT-3, p-mTOR and HIF-1α in hepatocellular carcinoma patients affected by metabolic dysfunctions and in chronic treatment with metformin. Int J Mol Sci. 20:2019. View Article : Google Scholar | |
|
Wen Y, Zhou X, Lu M, He M, Tian Y, Liu L, Wang M, Tan W, Deng Y, Yang X, et al: Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma. Oncogene. 38:1845–1859. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang G and Zhang G: Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncol Lett. 17:3944–3951. 2019.PubMed/NCBI | |
|
Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP and Wang HY: Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer. 11:2712011. View Article : Google Scholar : PubMed/NCBI | |
|
Kan H, Huang Y, Li X, Liu D, Chen J and Shu M: Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Oncotarget. 7:14336–14349. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Sun B, Li Y, Zhao X, Zhao X, Gu Q, An J, Dong X, Liu F and Wang Y: ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Exp Mol Pathol. 98:352–359. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wu D, Liu G, Liu Y, Saiyin H, Wang C, Wei Z, Zen W, Liu D, Chen Q, Zhao Z, et al: Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis through discs large 1-mediated yes-associated protein inactivation. Hepatology. 64:1148–1162. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yi PS, Wu B, Deng DW, Zhang GN and Li JS: Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma. Oncol Lett. 16:5122–5130. 2018.PubMed/NCBI | |
|
Xiang Q, Zhou D, He X, Fan J, Tang J, Qiu Z, Zhang Y, Qiu J, Xu Y and Lai G: The zinc finger protein GATA4 induces MET and cellular senescence through the NF-kappaB pathway in hepatocellular carcinoma. J Gastroenterol Hepatol. 2019. View Article : Google Scholar | |
|
Wang N, Wang S, Yang SL, Liu LP, Li MY, Lai PBS and Chen GG: Targeting ZBP-89 for the treatment of hepatocellular carcinoma. Expert Opin Ther Targets. 22:817–822. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Huang Y, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Zhang B, et al: Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma. Oncogenesis. 6:e3632017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Zhou Y, Miao R, Chen W, Qu K, Pang Q and Liu C: Transcriptional modules related to hepatocellular carcinoma survival: Coexpression network analysis. Front Med. 10:183–190. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yin L, Cai Z, Zhu B and Xu C: Identification of key pathways and genes in the dynamic progression of HCC based on WGCNA. Genes (Basel). 9:922018. View Article : Google Scholar | |
|
Xu W, Rao Q, An Y, Li M and Zhang Z: Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma. PLoS One. 13:e02027632018. View Article : Google Scholar : PubMed/NCBI | |
|
Li B, Pu K and Wu X: Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis. J Cell Biochem. Feb 11–2019.(Epub ahead of print). doi: 10.1002/jcb.28420. | |
|
Zhang C, Peng L, Zhang Y, Liu Z, Li W, Chen S and Li G: The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Med Oncol. 34:1012017. View Article : Google Scholar : PubMed/NCBI | |
|
Skinkyte-Juskiene R, Kogelman LJA and Kadarmideen HN: Transcription factor co-expression networks of adipose RNA-Seq data reveal regulatory mechanisms of obesity. Curr Genomics. 19:289–299. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xue F, Higgs BW, Huang J, Morehouse C, Zhu W, Yao X, Brohawn P, Xiao Z, Sebastian Y, Liu Z, et al: HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. J Transl Med. 13:3792015. View Article : Google Scholar : PubMed/NCBI | |
|
Collado-Torres L, Nellore A, Kammers K, Ellis SE, Taub MA, Hansen KD, Jaffe AE, Langmead B and Leek JT: Reproducible RNA-seq analysis using recount2. Nat Biotechnol. 35:319–321. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al: GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res. 22:1760–1774. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng G, Tu K, Yang Q, Xiong Y, Wei C, Xie L, Zhu Y and Li Y: ITFP: An integrated platform of mammalian transcription factors. Bioinformatics. 24:2416–2417. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Marbach D, Lamparter D, Quon G, Kellis M, Kutalik Z and Bergmann S: Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods. 13:366–370. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Neph S, Stergachis AB, Reynolds A, Sandstrom R, Borenstein E and Stamatoyannopoulos JA: Circuitry and dynamics of human transcription factor regulatory networks. Cell. 150:1274–1286. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Stergachis AB, Neph S, Sandstrom R, Haugen E, Reynolds AP, Zhang M, Byron R, Canfield T, Stelhing-Sun S, Lee K, et al: Conservation of trans-acting circuitry during mammalian regulatory evolution. Nature. 515:365–370. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang C, Xuan Z, Zhao F and Zhang MQ: TRED: A transcriptional regulatory element database, new entries and other development. Nucleic Acids Res. 35:D137–D140. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Han H, Shim H, Shin D, Shim JE, Ko Y, Shin J, Kim H, Cho A, Kim E, Lee T, et al: TRRUST: A reference database of human transcriptional regulatory interactions. Sci Rep. 5:114322015. View Article : Google Scholar : PubMed/NCBI | |
|
Love MI, Huber W and Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI | |
|
Mason MJ, Fan G, Plath K, Zhou Q and Horvath S: Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics. 10:3272009. View Article : Google Scholar : PubMed/NCBI | |
|
Langfelder P and Horvath S: WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI | |
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y and Morishima K: KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H and Vilo J: g:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 44:W83–W89. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Reimand J, Arak T and Vilo J: g:Profiler--a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res. 39:W307–W315. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H and Vilo J: g:Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47:W191–W198. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA and Bork P: STRING: Known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33:D433–D437. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan L, Qian G, Chen L, Wu CL, Dan HC, Xiao Y and Wang X: Co-expression network analysis of biomarkers for adrenocortical carcinoma. Front Genet. 9:3282018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen PF, Wang F, Nie JY, Feng JR, Liu J, Zhou R, Wang HL and Zhao Q: Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer. Onco Targets Ther. 11:6425–6436. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Janky R, Verfaillie A, Imrichová H, Van de Sande B, Standaert L, Christiaens V, Hulselmans G, Herten K, Naval Sanchez M, Potier D, et al: iRegulon: From a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol. 10:e10037312014. View Article : Google Scholar : PubMed/NCBI | |
|
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yin L, Guo X, Zhang C, Cai Z and Xu C: In silico analysis of expression data during the early priming stage of liver regeneration after partial hepatectomy in rat. Oncotarget. 9:11794–11804. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Menyhárt O, Nagy Á and Győrffy B: Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 5:1810062018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Hua L, Yan D, Zhao F, Liu J, Zhou H, Liu J, Wu M, Zhang C, Chen Y, et al: Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma. Oncol Rep. 36:3456–3464. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P and Haybaeck J: New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. Eur J Cancer. 83:56–70. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Poon RT: Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challenge. Hepatology. 54:757–759. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Vilarinho S and Calvisi DF: New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatment. Hepatology. 60:1812–1814. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shimagaki T, Yoshizumi T, Harimoto N, Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T and Maehara Y: MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection. Hepatol Res. 48:313–321. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chuma M, Toyoda H, Matsuzaki J, Saito Y, Kumada T, Tada T, Kaneoka Y, Maeda A, Yokoo H, Ogawa K, et al: Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Hepatol Res. 49:810–822. 2019.PubMed/NCBI | |
|
Song S, Yang Y, Liu M, Liu B, Yang X, Yu M, Qi H, Ren M, Wang Z, Zou J, et al: MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6. Am J Cancer Res. 8:993–1007. 2018.PubMed/NCBI | |
|
Zhang Q, Cao LY, Cheng SJ, Zhang AM, Jin XS and Li Y: p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB. Oncol Rep. 33:1335–1341. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Z, Meng C, Wang S, Zhou N, Guan M, Bai C, Lu S, Han Q and Zhao RC: MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma. BMC Cancer. 14:6162014. View Article : Google Scholar : PubMed/NCBI | |
|
Chan HM, Narita M, Lowe SW and Livingston DM: The p400 E1A-associated protein is a novel component of the p53 -->p21 senescence pathway. Genes Dev. 19:196–201. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Shi M, Chen MS, Sekar K, Tan CK, Ooi LL and Hui KM: A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. Eur J Cancer. 50:928–936. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Montalvá EM, Cantos M, Boscà A, Rubín A, Vinaixa C, Granero P, Maupoey J and López-Andújar R: Prognostic value of pre-transplantation serum alpha-fetoprotein levels in hepatocellular carcinoma recurrence. Transplant Proc. 48:2966–2968. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tsukamoto M, Nitta H, Imai K, Higashi T, Nakagawa S, Okabe H, Arima K, Kaida T, Taki K, Hashimoto D, et al: Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma. Hepatol Res. 48:E183–E193. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Carrascoso I, Alcalde J, Tabas-Madrid D, Oliveros JC and Izquierdo JM: Transcriptome-wide analysis links the short-term expression of the b isoforms of TIA proteins to protective proteostasis-mediated cell quiescence response. PLoS One. 13:e02085262018. View Article : Google Scholar : PubMed/NCBI | |
|
Tak H, Kang H, Ji E, Hong Y, Kim W and Lee EK: Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma. Biochem Biophys Res Commun. 497:1117–1122. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Subramaniam K, Ooi LL and Hui KM: Transcriptional down-regulation of IGFBP-3 in human hepatocellular carcinoma cells is mediated by the binding of TIA-1 to its AT-rich element in the 3′-untranslated region. Cancer Lett. 297:259–268. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Y, Mao W, Dong M, Yang D, Li W and Chen Y: Serum insulin-like growth factor-1 (IGF-1): A novel prognostic factor for early recurrence of hepatocellular carcinoma (HCC). Clin Lab. 63:261–270. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Shao C, Kong Y, Carlock C, Ahmad N and Liu X: DNA damage response-independent role for MDC1 in maintaining genomic stability. Mol Cell Biol. 37:2017. View Article : Google Scholar | |
|
Lee JH, Park SJ, Hariharasudhan G, Kim MJ, Jung SM, Jeong SY, Chang IY, Kim C, Kim E, Yu J, et al: ID3 regulates the MDC1-mediated DNA damage response in order to maintain genome stability. Nat Commun. 8:9032017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Zou Z, Luo X, Mi Y, Chang H and Xing D: LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer. Oncogene. 37:3243–3259. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou H, Qin Y, Ji S, Ling J, Fu J, Zhuang Z, Fan X, Song L, Yu X and Chiao PJ: SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Oncogene. 37:912–923. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bailey SD, Zhang X, Desai K, Aid M, Corradin O, Cowper-Sal Lari R, Akhtar-Zaidi B, Scacheri PC, Haibe-Kains B and Lupien M: ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nat Commun. 2:61862015. View Article : Google Scholar : PubMed/NCBI | |
|
Ishiguchi H, Izumi H, Torigoe T, Yoshida Y, Kubota H, Tsuji S and Kohno K: ZNF143 activates gene expression in response to DNA damage and binds to cisplatin-modified DNA. Int J Cancer. 111:900–909. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Paek AR, Lee CH and You HJ: A role of zinc-finger protein 143 for cancer cell migration and invasion through ZEB1 and E-cadherin in colon cancer cells. Mol Carcinog. 53 (Suppl 1):E161–E168. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kawatsu Y, Kitada S, Uramoto H, Zhi L, Takeda T, Kimura T, Horie S, Tanaka F, Sasaguri Y, Izumi H, et al: The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma. Br J Cancer. 110:2583–2592. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Haibara H, Yamazaki R, Nishiyama Y, Ono M, Kobayashi T, Hokkyo-Itagaki A, Nishisaka F, Nishiyama H, Kurita A, Matsuzaki T, et al: YPC-21661 and YPC-22026, novel small molecules, inhibit ZNF143 activity in vitro and in vivo. Cancer Sci. 108:1042–1048. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ruosi C, Colella G, Fazioli F, Miceli R, Gallo M, Di Salvatore MG, Cimmino A and de Nigris F: Yin Yang I as an epimodulator of miRNAs in the metastatic cascade. Crit Rev Oncog. 22:99–107. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cho AA and Bonavida B: Targeting the overexpressed YY1 in cancer inhibits EMT and metastasis. Crit Rev Oncog. 22:49–61. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Meng J, Chen S, Wang X, Yin S, Zhang Q, Liu H, Qin R, Li Z, Zhong W, et al: YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 79:1451–1464. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong S, Ma X, Wang Z, Han B, Zou H, Wu Z, Zang Y and Zhuang L: YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor. Oncotarget. 8:40583–40593. 2017.PubMed/NCBI | |
|
Kim JS, Son SH, Kim MY, Choi D, Jang IS, Paik SS, Chae JH, Uversky VN and Kim CG: Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma. Oncotarget. 8:24389–24400. 2017.PubMed/NCBI | |
|
Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, et al: Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. J Pathol. 238:651–664. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Jiang T, Feng L, Sun J, Lu H, Wang Q, Pan M, Huang D, Wang X, Wang L and Jin H: Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. J Mol Med (Berl). 90:1069–1077. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Teng CF, Wu HC, Tsai HW, Shiah HS, Huang W and Su IJ: Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. Hepatology. 54:1199–1207. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Moldovan GL and D'Andrea AD: How the fanconi anemia pathway guards the genome. Annu Rev Genet. 43:223–249. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ferroudj S, Yildiz G, Bouras M, Iscan E, Ekin U and Ozturk M: Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance. Hepatol Res. 46:1264–1274. 2016. View Article : Google Scholar : PubMed/NCBI |
